Involvement of serum apolipoprotein AI and B100 and lecithin cholesterol acyl transferase in alcoholic cirrhotics

Annals of Hepatology

Volumn 6, Issue 4, 2007, Pages 227-232

  Lemberg, Abraham ^a   Schreier, Laura ^a   Romay, Salvador ^a   Fernández, Maria Alejandra ^a   Rosello, Diego ^a   Gonzales, Soledad ^a   Perazzo, Juan Carlos ^a   Filinger, Ester Julia ^a   Tomaro, Maria Lujan ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Alcoholic cirrhosis; Lipoproteins; Oxidative stress

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; CATALASE; CHOLINESTERASE; GLUTATHIONE PEROXIDASE; LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL ESTERIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; LIPID DIET; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; OXIDATIVE STRESS; PROTEIN SYNTHESIS;

EID: 37549061746     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31903-9     Document Type: Article

References (52)

1. Greten H. Biochemistry, metabolism, epidemiology, pp 1-10 in lipoproteins and coronary heart disease, edited H. Greten, PD. Lang, G. Schettler. Gerhard Witzstrock - Publishing House, New York, Baden Baden, Cologne 1980.
2. Bremer HB, Schaefer EJ, Zech LA, Osborne JC. Human plasma lipoproteins, structure function and metabolism, pp 7-15 in lipoproteins and coronary heart disease, edited H. Greten, PD. Lang, G. Schettler. Gerhard Witzstrock - Publishing House, New York, Baden Baden, Cologne 1980.
3. Kroon P A, Powell EE. Liver lipoproteins and disease. Biochemistry of lipoprotein metabolism. Hepatol 1992; 7: 214-24.
4. Schreier L. Sobre el perfil de las subfracciones lipoproteicas plasmáticas, Papel del hígado; in Lipoproteínas. Academia Nacional de Ciencias, Bs. As, Argentina. 2004; 57: 17-24.
5. Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair KS. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology 2002; 35: 898-904.
6. Kaplowitz N. Mechanisms of liver cell injury. J Hepatol. 2000; 32(S): 39-47.
7. Hezode C, Roudot-Thoraval F, Zafrani ES, Dhumeaux D, Pawlotsky JM. Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections. J Viral Hepat 2004; 11: 455-8.
8. Walsh MJ, Vanags DM, Clouston AD, Richardson MM, Purdie DM, Jonsson JR, Powell EE. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury. Hepatology 2004; 39: 1230-8.
9. Crocker JFS. Reye's syndrome. Seminars in Liver Disease, 1982; 2: 340-52.
10. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci 2002; 65: 166-76.
11. Lonardo A, Adinolfi LE, Loria P, Carulli N, Ruggiero G, Day CP. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology 2004; 126: 586-97.
12. Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair KS. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology 2002; 35: 898-904.
13. Wu D, Cederbaum AI. Alcohol, oxidative stress, and free radical damage. Alcohol Res Health 2003; 27: 277-84.
14. Fernandez-Checa JC. Alcohol- induced liver disease: When fat and oxidative stress meet. Annals of Hepatology 2003; 2: 69-75.
15. Kaplowitz N, Tsukamoto H. Oxidative stress and liver disease. Prog Liver Dis 1996; 14: 131-59.
16. Tuma DJ, Casey CA. Dangerous byproducts of alcohol break-down-focus on adducts. Alcohol Res Health 2003; 27: 285-90.
17. Neuman MG. Cytokines-central factors in alcoholic liver disease. Alcohol Res Health 2003; 27: 307-16.
18. De Groot H. Reactive oxygen species in tissue injury. Hepatogastroenterology 1994; 41: 328-32.
19. Fernandez-Checa JC, Kaplowitz N, Colell A, Garcia-Ruiz C. Oxidative stress and alcoholic liver disease. Alcohol Health Res World 1997; 21: 321-4.
20. Adachi M, Ishii H. Role of mitochondria in alcoholic liver injury. Free Radical Biol Med 2002; 32: 487-91.
21. Dringen R, Gutteres JM, Hinrenger. Glutathione metabolism in brain: interaction between astrocytes and neurons in the defense, against reactive oxygen species. Eur J Biochem 2001; 967: 4910-16.
22. Fernandez-Checa JC, Kaplowitz N. Hepatic mitochondrial glutathione: transport and role in disease and toxicity. Toxicology and Applied Pharmacology 2005; 204: 263-73.
23. Hirano T, Kaplowitz N, Tsukamoto H, Kamimura S, Fernandez-Checa J. Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats. Hepatology 1992; 16: 1423-7.
24. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Wiliams R. Transection of the oesophagus for bleeding oesophageal varices. Brit J Surg 1973; 60: 646-54.
25. Lowry HO, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin reagent. J Biol Chem 1951; 193: 265-75.
26. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59: 527-605.
27. Flohé L, Gunzler WA. Assays of glutathione peroxidase. Meth Enzymol 1984; 105: 114-21.
28. Buege JA, Aust SD. Microsomal lipid peroxidation. Meth Enzymol 1978; 52: 302-10.
29. Mathur SN, Born E, Murthy S, Field FJ. Phosphatidylcholine increase the secretion of triacyl-glyceron-rich lipoproteins by CaCo-2 cells. Biochem J 1996; 314: 569-75.
30. Zhou Z, Luchoomun J, Bakillah A, Hussain MM. Lysophosphatidylcholine increases apolipoprotein B secretion by enhancing lipid synthesis and decreasing its intracellular degradation in HepG2 cells. Biochimica et Biophysica Acta 1998; 1391: 13-24.
31. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996; 271: 518-20.
32. Arai T, Wang N, Bezouevski M, Welch C, Tall AR. Decreased atherosclerosis in heterozygous low density lipoprotein receptordeficient mice expressing the scavenger receptor BI transgene. J Biol Chem 1999; 274: 2366-71.
33. Kozarsky KF, Donahee MH, Rigotti A, Iqbal SN, Edelman ER, Krieger M. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 1997; 387: 414-7.
34. Nibbering CP, Groen AK, Ottenhoff R, Brouwers JF, vanBerge-Henegouwen GP, van Erpecum KJ. Regulation of biliary cholesterol secretion is independent of hepatocyte canalicular membrane lipid composition: a study in the diosgenin-fed rat model. J Hepatol 2001; 35: 164-9.
35. Berg GA. Lipasa hepática, efectos sobre el metabolismo lipídico y lipoproteico. Acta Bioq Clin Latinoam 2001; 35: 201-24.
36. Thierry C, Yusuke I, Barbier O, Duran-Sandoval D, Kosykh V, Fruchart J, Fruchart JC, Gonzalez FJ, Staels B. Farnesoid X receptor agonists suppress hepatic apolipoproteína CIII expression. Gastroenterology 2003; 125: 544-55.
37. Oude Elferink RP, Groen AK. Mechanisms of biliary lipid secretion and their role in lipid homeostasis. Semin Liver Dis 2000; 20: 293-305.
38. Schoonjans K, Staels B, Auwerx J. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1996; 1302:93-109.
39. Handschin C, Meyer UA. Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR. Arch Biochem Biophys 2005; 433: 387-96.
40. Cunard R, Ricote M, DiCampli D, Archer DC, Kahn DA, Glass CK, Kelly CJ. Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors. J Immunol 2002; 168: 2795-802.
41. Peelman F, Vandekerckhove J, Rosseneu M. Structure and function of lecithin cholesterol acyl transferase: new insights from structural predictions and animal models. Curr Opin Lipidol 2000; 11: 155-60.
42. Glomset JA, Janssen EJ, Kennedy R, Dobbins J. Role of plasma lecithin cholesteryl acyl transferase in the metabolismof high density lipoproteins. J Lip Res 1966; 7: 638-48.
43. Brites F, Fernandez K, Yael M, Wikinski R. Evolution of a patient with a partial deficiency of lecithin acyl cholesterol transferase. Medicina 2000; 60: 406-7.
44. De Vries R, Borggreve SE, Dullaart RP. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus. Clin Lab 2003; 49: 601-13.
45. McCord JM. Iron, free radicals, and oxidative injury. J Nutr 2004; 134: 3171S-2S.
46. Zhao P, Kahon TF, Slattery JI. Selective mitochondrial glutathione depletion by ethanol, enhances acetoaminophen toxicity in rat liver. Hepatology 2002; 36: 326-35.
47. Fernandez-Checa JC, Kaplowitz N, Garcia-Ruiz C, Colelli A. Mitochondrial glutathione importance and transport. Semin liver Dis 1998; 18: 389-401.
48. Fernandez-Checa JC, Garcia-Ruiz C, Ookhtens M, Kaplowitz N. Impaired uptake of glutathione by hepatic mitochondria from chronic etanol-fed rats. Tracer kinetic stiudies in vitro and in vivo and susceptibility to oxidant stress. J Clin Invest 1991; 87: 397-403.
49. Krähenbühl S, Talos C, Lauterburg BH, Reichen J. Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats. Hepatology 1995; 22: 607-12.
50. Bengoechea L, Ouviña G, Zozzami P, Lemberg A. Protein and lipid disturbance in rat liver microsomal membranes after bile duct ligation. Biochem Biosphys Res Comm 1987; 144: 980-5.
51. Mari M, Caballero F, Colleli A, Morales A, Caballero J, Fernandez-Checa JC, Garcia-Ruiz C. Mitochondrial free cholesterol loading sensitizes to TNF and Fas mediated steatohepatitis. Cell Metab 2006; 4: 179-81.
52. Meagher EA, Barry OP, Burke A, Lucey MR, Lawson JA, Rokach J, FitzGerald GA. Alcohol-induced generation of lipid peroxidation products in humans. J Clin Invest 1999; 104: 805-13.